STOCK TITAN

XMax receives Nasdaq reprimand; listing unaffected

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(High)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
8-K

Rhea-AI Filing Summary

XMax Inc. received a Nasdaq Letter of Reprimand closing the exchange staff’s review of its failure to obtain shareholder approval for certain below-Minimum-Price share issuances. The December 19, 2025 issuance was 1,187,500 shares at $4.21 per share; Nasdaq’s Official Closing Price on December 18, 2025 was $6.02, and its five-day average closing price was $5.98. Three additional discounted issuances in March and April 2026 involved 8,500,000, 1,958,000 and 8,550,000 shares. Nasdaq said the issuances together exceeded 20% of common stock outstanding and were priced below the Minimum Price.

Shareholders ratified the issuances at a special meeting on November 2, 2026. Nasdaq determined delisting was not an appropriate sanction and closed the matter with the reprimand; the letter does not affect XMAX’s Nasdaq listing or trading. Nasdaq noted future violations of its shareholder-approval rules may result in a Staff Delist Determination.

Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing Securities
The company received a delisting notice, failed to satisfy a continued-listing rule or standard, or transferred its listing.
December Issuance 1,187,500 shares Issued at $4.21 per share on December 19, 2025.
December Issuance price $4.21 per share Offering price on December 19, 2025.
Nasdaq Official Closing Price $6.02 per share As of December 18, 2025.
Five-day average Nasdaq Official Closing Price $5.98 per share For the five-day period ended December 18, 2025.
March 9, 2026 discounted issuance 8,500,000 shares One of three additional issuances priced below the Minimum Price.
March 30, 2026 discounted issuance 1,958,000 shares One of three additional issuances priced below the Minimum Price.
April 24, 2026 discounted issuance 8,550,000 shares One of three additional issuances priced below the Minimum Price.
Aggregated issuance threshold Greater than 20% of common stock outstanding Nasdaq said the aggregated issuances were priced below the Minimum Price.
Letter of Reprimand regulatory
"close the matter by issuing the Reprimand Letter"
Listing Rule 5635(d) regulatory
"requires shareholder approval prior to a “20% Issuance”"
Minimum Price regulatory
"the December Issuance was therefore priced below the Minimum Price"
The minimum price is the lowest allowable or acceptable price at which a security, share offering, product, or sale can be bought or sold. Think of it like the smallest tag on a store item that the seller will accept; for investors it sets a floor for entry or sale, affects potential returns and liquidity, and can influence demand by limiting purchases below that level.
Nasdaq Official Closing Price financial
"The Nasdaq Official Closing Price of the Company’s common stock"
Staff Delist Determination regulatory
"may result in a Staff Delist Determination"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What happened to XMAX’s Nasdaq listing after the reprimand?

Nasdaq closed its review with a Letter of Reprimand and said delisting was not an appropriate sanction. The letter has no effect on XMAX’s listing or trading, and the common stock will continue trading on Nasdaq. Nasdaq noted that future violations of its shareholder-approval rules may result in a Staff Delist Determination.

Why did XMAX receive a Nasdaq Letter of Reprimand?

Nasdaq said XMAX did not obtain prior shareholder approval for aggregated issuances that exceeded 20% of common stock outstanding and were priced below the Minimum Price. Shareholders ratified the issuances at a special meeting on November 2, 2026, and Nasdaq cited that ratification and the absence of a demonstrated prior pattern of non-compliance in deciding to close the matter with a reprimand.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
false 0001473334 0001473334 2026-11-16 2026-11-16 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

 

FORM 8-K

 

 

 

CURRENT REPORT

 

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): November 16, 2026

 

XMAX Inc.

(Exact name of registrant as specified in its charter)

 

Nevada   001-36259   90-0746568
(State or Other Jurisdiction   (Commission   (I.R.S. Employer
of Incorporation)   File Number)   Identification No.)

 

6565 E. Washington Blvd., Commerce, CA 90040

(Address of Principal Executive Office) (Zip Code)

 

(323) 888-9999

(Registrant’s telephone number, including area code)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
   
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
   
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
   
☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company ☐

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
Common Stock, par value $0.001 per share   XMAX   Nasdaq Stock Market

 

 

 

 
 

 

Item 3.01. Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

 

On November 16, 2026, XMAX, Inc. (the “Company”) received a Letter of Reprimand (the “Reprimand Letter”) from the Listing Qualifications Department (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) in connection with the Company’s previously disclosed failure to comply with Nasdaq Listing Rule 5635(d) (the “Rule”), which requires shareholder approval prior to a “20% Issuance” at a price less than the “Minimum Price” (as defined in Listing Rule 5635(d)(1)(A)). As previously reported in the Company’s Current Report on Form 8-K filed with the Securities and Exchange Commission on September 15, 2026, the Company received a notification letter from Staff on September 10, 2026 regarding its non-compliance with the Rule. The Reprimand Letter advises that Staff has completed its review of the circumstances underlying the non-compliance and has determined to close the matter by issuing the Reprimand Letter in accordance with Listing Rule 5810(c)(4).

 

As described in the Reprimand Letter, on December 19, 2025, the Company entered into a Securities Purchase Agreement with two investors to issue 1,187,500 shares of common stock at an offering price of $4.21 per share (the “December Issuance”). The Nasdaq Official Closing Price of the Company’s common stock was $6.02 as of December 18, 2025, and the five-day average Nasdaq Official Closing Price for the period then ended was $5.98. The December Issuance was therefore priced below the Minimum Price.

 

Subsequently, in March and April of 2026, the Company entered into five additional private placement transactions. Three of the five additional transactions, specifically 8,500,000 shares for March 9, 2026 transaction, 1,958,000 shares for March 30, 2026 transaction and 8,550,000 shares for April 24, 2026 transaction were issued at a price less than the Minimum Price (the “March and April Discounted Issuances”).

 

The December Issuance, aggregated with the March and April Discounted Issuances (the “Aggregated Issuance”), represents greater than 20% of the common stock outstanding and was priced below the Minimum Price, and the Company was required to obtain prior shareholder approval under Listing Rule 5635(d), which it did not obtain.

 

Staff determined that delisting the Company’s securities is not an appropriate sanction and that it is appropriate to close the matter by issuing the Reprimand Letter because the Company’s shareholders ratified the Aggregated Issuances at a special meeting of shareholders held on November 2, 2026 and the Company has not demonstrated a prior pattern of non-compliance. The Reprimand Letter also notes that future violations of Nasdaq’s shareholder approval rules may result in a Staff Delist Determination.

 

The Reprimand Letter closes the matter and has no effect on the listing or trading of the Company’s common stock, which will continue to trade on the Nasdaq Stock Market under the symbol “XMAX.”

 

 
 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.

 

  XMax Inc.
   
  /s/ Xiaohua Lu
  Xiaohua Lu
  Chief Executive Officer
   
November 16, 2026  

 

 

Filing Exhibits & Attachments

3 documents

Keep reading